ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...
On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...
CPAP therapy, the traditional standard for obstructive sleep apnea (OSA), is universally despised by patients, resulting in abysmally low compliance rates. Recent studies show it also fails to ...
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 ...
The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 billion in 2024 and an impressive US$ 1.45 billion by 2029 ...
Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Sleep Apnea Devices market size was valued at USD 5.25 billion in 2023 and is expected to reach USD 9.43 billion by 2032, growing ...
When most people think about sleep apnea, I’d assume they think of snoring. Snoring is just one type of sleep apnea that most ...
Obstructive sleep apnea (OSA) is very common (15 per cent to 30 per cent of men in the United States and 10 per cent to 15 ...
Obstructive sleep apnea (OSA) is very common with 15% to 30% of men in the United States and 10% to 15% of women having the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback